Quick answer
This page lists 28 hormone therapy doctors in Delhi NCR, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Hormone Therapy doctors in Delhi NCR, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Hormone Therapy doctors
FeaturedDr. Ajay Sharma
MBBS, MD, DNB, ECMO
Senior Director & Unit Head — Medical Oncology · Specialty: Medical Oncologist
BLK-Max Super Speciality Hospital New Delhi, India18+ Years experience
Why consider this doctor?
- 18+ years of experience in Medical Oncologist
- Senior Director and Unit Head, Medical Oncology — BLK-Max Super Speciality Hospital, New Delhi (Present)
- Unit Head and Senior Consultant, Medical Oncology — Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (2022–2023)
Expertise & Procedures
- Adjuvant chemotherapy for solid tumours
- Neoadjuvant chemotherapy planning and delivery
- Immunotherapy and checkpoint inhibitor therapy
- Hormone therapy for breast cancer
- Molecular-targeted therapy based on biomarkers
Medical Oncologist Experience: 18+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Dr. Ankur Bahl
MBBS, MD, DM
Principal Director — Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurugram, India17+ Years experience
Why consider this doctor?
- 17+ years of experience in Medical Oncologist
- Principal Director, Medical Oncology — Fortis Memorial Research Institute, Gurugram (Present)
- Director, Medical Oncology and Haematology Oncology — Max Hospital, Saket (Previous)
Expertise & Procedures
- Chemotherapy for Solid Tumours
- Immune Checkpoint Inhibitor Therapy
- Targeted Molecular Therapy
- Neoadjuvant Chemotherapy
- Adjuvant Chemotherapy
Medical Oncologist Experience: 17+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Anshul Gupta
MBBS, MD, DM (Medical Oncology)
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospital Delhi NCR, India12+ Years experience
Why consider this doctor?
- 12+ years of experience in Medical Oncologist
- Senior Consultant – Medical Oncology, Indraprastha Apollo Hospital, Delhi NCR, Present
- Medical Oncologist, AIIMS New Delhi, Previous roles
Expertise & Procedures
- Chemotherapy Administration & Management
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy for Cancer
- CAR-T Cell Therapy
- Hormone Therapy (Breast & Prostate)
Medical Oncologist Experience: 12+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Ashutosh Jain
MBBS, MD, DM
Associate Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India8+ Years experience
Why consider this doctor?
- 8+ years of experience in Medical Oncologist
- Associate Consultant, Department of Medical Oncology, Fortis Memorial Research Institute, Gurgaon — Present
- Medical Oncology Training and Clinical Practice, Tata Memorial Research Institute, Mumbai — Previous affiliation
Expertise & Procedures
- Chemotherapy for Solid Tumors
- Adjuvant Chemotherapy
- Neoadjuvant Chemotherapy
- Palliative Chemotherapy
- Immunotherapy for Solid Tumors
Medical Oncologist Experience: 8+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Bhuvan Chugh
MBBS, DNB (Medicine), DNB (Medical Oncology)
Lead Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospital New Delhi, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Medical Oncologist
- Lead Consultant, Medical Oncology – Indraprastha Apollo Hospital, New Delhi
- Principal Consultant, Medical Oncology – Max Super Specialty Hospital, Saket, New Delhi
Expertise & Procedures
- Chemotherapy Administration and Management
- Cancer Immunotherapy Planning and Delivery
- Targeted Therapy for Breast and Lung Cancer
- Hormone Therapy for Breast Cancer
- CAR-T Cell Therapy Evaluation and Management
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Anil Dhar
MBBS, MD, Post-doctoral training in Medical Oncology
Clinical Director & Head — Medical Oncology · Specialty: Medical Oncologist
Marengo Asia Hospitals Gurugram, India35+ Years experience
Why consider this doctor?
- 35+ years of experience in Medical Oncologist
- Clinical Director & Head, Medical Oncology – Marengo Asia Hospitals, Gurugram (Present)
- Senior Consultant & Mentor – Multiple Oncology Programs across India
Expertise & Procedures
- Adjuvant Chemotherapy for Solid Tumors
- Neoadjuvant Chemotherapy and Surgery Coordination
- Targeted Therapy with Biomarker Analysis
- Immunotherapy for Advanced Cancers
- Hormone Therapy for Breast Cancer
Medical Oncologist Experience: 35+ YearsHospital Affiliation: Marengo Asia HospitalsHospital accreditation: NABH, NABL
Dr. Devanshee Aakash Shah
MBBS, MD, DM, ECMO Certification, Harvard Medical School eDiploma, ESMO Certification
Associate Consultant — Medical Oncology · Specialty: Medical Oncologist
Paras Hospitals Gurugram, India8+ Years experience
Why consider this doctor?
- 8+ years of experience in Medical Oncologist
- Associate Consultant, Medical Oncology — Paras Hospitals, Gurugram (Present)
- Assistant Professor — Tata Memorial Hospital, Mumbai (Former)
Expertise & Procedures
- Chemotherapy for Solid Tumors
- Adjuvant and Neoadjuvant Chemotherapy
- Immunotherapy with Checkpoint Inhibitors
- Molecular Targeted Therapy
- Hormone Therapy for Breast Cancer
Medical Oncologist Experience: 8+ YearsHospital Affiliation: Paras HospitalsHospital accreditation: NABH, NABL
Dr. Devender Sharma
MD, Fellowship, Certificate Course
Associate Consultant — Medical Oncology · Specialty: Medical Oncologist
Medanta - The Medicity Gurugram, India16+ Years experience
Why consider this doctor?
- 16+ years of experience in Medical Oncologist
- Associate Consultant, Medical Oncology — Medanta — The Medicity, Gurugram
- Over 16 years of clinical experience in oncology, spanning diagnosis and management of solid tumors, hematologic malignancies, and palliative cancer care
Expertise & Procedures
- Chemotherapy Protocol Design and Administration
- Adjuvant Chemotherapy for Solid Tumors
- Neoadjuvant Chemotherapy Planning
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
Medical Oncologist Experience: 16+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Ghazal Tansir
MBBS, MD, DNB, DM
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospital New Delhi, India9+ Years experience
Why consider this doctor?
- 9+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology — Indraprastha Apollo Hospital, New Delhi (Present)
- Apollo Athenea Women's Cancer Center, Delhi (Present)
Expertise & Procedures
- Personalized Chemotherapy Planning and Administration
- Cancer Immunotherapy (Checkpoint Inhibitors and Monoclonal Antibodies)
- Targeted Molecular Therapy for Solid Tumours
- Hormone Therapy for Breast and Gynecologic Cancers
- CAR-T Cell Therapy Coordination and Management
Medical Oncologist Experience: 9+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Hari Goyal
MBBS, MD, DM (Medical Oncology), ICH-GCP Certification
Chief — Medical Oncology · Specialty: Medical Oncologist
Artemis Hospital Gurgaon, India27+ Years experience
Why consider this doctor?
- 27+ years of experience in Medical Oncologist
- Chief, Medical Oncology — Artemis Hospital, Gurgaon (Current)
- Consultant Medical Oncologist — Tata Memorial Hospital, Mumbai
Expertise & Procedures
- Targeted Therapy for Solid Tumours
- Cancer Immunotherapy Administration
- Systemic Chemotherapy Protocols
- Hormone Therapy for Breast Cancer
- Hormone Therapy for Gynaecological Cancers
Medical Oncologist Experience: 27+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 New Delhi, IndiaStarting from$600
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Hormone Therapy
3.8
48 reviews
650+
Beds
67+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$600
Fortis Memorial Research Institute
Est. 1996
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Hormone Therapy
4.8
1100 reviews
1000+
Beds
30+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$600
Apollo Hospitals
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
6+
Doctors for Hormone Therapy
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$600
Apollo Hospitals, Greams Road
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Hormone Therapy
4.7
125 reviews
560+
Beds
43+
Years Since Founded
🇮🇳 Sector 56, Gurgaon, IndiaStarting from$600
Marengo Asia Hospitals Gurgaon
Est. 1995
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Hormone Therapy
4.4
103 reviews
110+
Beds
31+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$600
Paras Hospitals
Est. 2006
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Hormone Therapy
4.4
59 reviews
300+
Beds
20+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$600
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
5+
Doctors for Hormone Therapy
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$600
Artemis Hospital
Est. 2007
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Hormone Therapy
4.9
64 reviews
750+
Beds
19+
Years Since Founded
🇮🇳 Shalimar Bagh, New Delhi, IndiaStarting from$600
Fortis Hospital, Shalimar Bagh
Est. 2010
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Hormone Therapy
4.5
68 reviews
262+
Beds
16+
Years Since Founded
🇮🇳 Faridabad, IndiaStarting from$600
Marengo Asia Hospitals
Est. 2007
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Hormone TherapyMedical OncologyCardiac SurgeryCardiology
1+
Doctors for Hormone Therapy
4.4
54 reviews
450+
Beds
19+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for prostate & other urological cancers treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Hormone Therapy?
Hormone therapy uses medications or surgery to block or lower the effect of hormones that fuel certain cancers, most commonly hormone receptor-positive breast cancer and prostate cancer. It is used as a primary treatment, alongside surgery/radiation, or to reduce recurrence risk, and can be delivered as daily oral tablets, periodic injections, or surgical hormone ablation. GAF Healthcare connects patients with leading Indian oncologists offering evidence-based hormone therapy protocols with close monitoring and significant cost savings compared to Western countries.
Who may be considered?
Hormone Therapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Daily oral medication that blocks estrogen receptors or lowers estrogen production, used for hormone receptor-positive breast cancer, typically for 5-10 years with periodic monitoring.
3 approaches available for this procedure:
Oral Hormone Therapy (Tamoxifen / Aromatase Inhibitors) – Breast Cancer
Most CommonDaily oral medication that blocks estrogen receptors or lowers estrogen production, used for hormone receptor-positive breast cancer, typically for 5-10 years with periodic monitoring.
Comprehensive Investigations
Estimated cost: $300 - $800
Hormone receptor (ER/PR/HER2) testing, CBC, liver function tests (LFT), bone density scan (DEXA), pelvic ultrasound, mammogram
Treatment / Procedure Estimate
Estimated cost in India: $600 - $1,800
Stay in India
Pre-procedure stay (outside hospital): ~1-2 days
Hospitalisation: ~0-1 day (outpatient)
Recovery period (outside hospital): Ongoing, reviewed every 3-6 months
Total stay: approx 2-3 days for initial visit
Usually Included in Hospital Package
- Oncologist consultation
- Baseline lab and imaging review
- Medication prescription and initiation
- Treatment plan documentation
- Care coordinator support
Usually Not Included
- Ongoing medication supply after leaving India
- Long-term DEXA/imaging follow-up abroad
- Airfare and accommodation
- Management of unrelated pre-existing conditions
Recovery and follow-up
Oral and injectable hormone therapies are typically continued for months to years with follow-up every 3-6 months to monitor hormone levels, bone density, and side effects, while surgical hormone ablation requires about 1-2 weeks of physical recovery before resuming normal activities.
Risks
Common risks include hot flashes, fatigue, mood changes, reduced bone density, and increased cardiovascular or blood clot risk with long-term hormone therapy; surgical ablation carries standard surgical risks such as bleeding or infection and is irreversible.
Alternatives
Alternatives include chemotherapy, targeted therapy (e.g., HER2-directed agents), radiation therapy, definitive surgery (mastectomy or radical prostatectomy), or active surveillance for select low-risk cases.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Pathology/biopsy report confirming cancer type and hormone receptor status
- PSA levels and trend (for prostate cancer)
- Mammogram/breast imaging or CT/bone scan (as applicable)
- Recent CBC and liver function tests (LFT)
- Bone density (DEXA) scan report, if available
- Details of prior treatments (surgery, chemotherapy, radiation)
- Latest oncologist consultation notes and treatment plan
- List of current medications and allergies
Patient information needed
- Patient age, gender, and menopausal status (for breast cancer)
- Type and stage of cancer
- Current and past hormone-related or cancer medications
- Comorbidities such as diabetes, heart disease, or osteoporosis
- History of blood clots or cardiovascular disease
- Family history of hormone-sensitive cancers
- Availability of a travel companion/caregiver
- Preferred treatment start date and duration of stay in India
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Hormone Therapy) and procedure (Hormone Therapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Hormone Therapy in Delhi NCR, India
What is Prostate & Other Urological Cancers?
Prostate and other urological cancers are malignant tumours that develop in organs of the urinary and male reproductive system — most commonly the prostate gland, but also the bladder, kidneys, and testes. They differ significantly in their rate of growth, risk of spread, and response to treatment, meaning each case requires individual evaluation.
What are the symptoms and health risks of Prostate & Other Urological Cancers?
Symptoms differ by cancer type and stage: prostate cancer may cause difficulty urinating, weak urine flow, blood in urine or semen, or pelvic discomfort, while bladder cancer often presents with painless blood in the urine, and kidney cancer may produce flank pain, a palpable mass, or unexplained weight loss. In early stages, many urological cancers produce no symptoms at all, making incidental detection through screening or imaging particularly important. These symptoms can also be caused by non-cancerous conditions, so their presence alone is not sufficient to establish a diagnosis.
How is Prostate & Other Urological Cancers diagnosed?
Diagnosis typically begins with a detailed clinical history and physical examination — including a digital rectal exam (DRE) for suspected prostate cancer — followed by blood tests such as PSA (prostate-specific antigen) for prostate cancer or urine cytology for bladder cancer. Imaging studies including ultrasound, CT, or MRI are used to assess tumour size, location, and potential spread, and a tissue biopsy is usually required to confirm malignancy and determine the tumour's grade. For prostate cancer, the Gleason score and Grade Group are key grading tools, while bladder and kidney cancers are staged using the TNM (Tumour-Node-Metastasis) system to guide treatment planning.
How is Prostate & Other Urological Cancers treated?
Treatment decisions depend on the cancer type, grade, stage, and the patient's overall health and preferences, and are best made by a multidisciplinary team. Options range from active surveillance for low-risk, slow-growing prostate cancer, to medical treatments such as hormone therapy, chemotherapy, and targeted therapy, as well as surgical interventions (such as radical prostatectomy, nephrectomy, or cystectomy) and radiation therapy. No single approach is universally appropriate, and a qualified oncologist will weigh the potential benefits and risks in the context of each individual's clinical profile.
Can Prostate & Other Urological Cancers be treated without a procedure?
Meaningful non-surgical pathways exist for many urological cancers: active surveillance (regular PSA testing, imaging, and repeat biopsy) is a recognised standard of care for carefully selected low-risk prostate cancers, while hormone therapy (androgen deprivation therapy), chemotherapy, and targeted or immunotherapy agents are established treatments for locally advanced or metastatic disease. Radiation therapy — delivered externally or via brachytherapy — is another non-surgical option for eligible patients. The appropriateness of each approach depends on an individualised assessment by a treating specialist.
When is Hormone Therapy considered for Prostate & Other Urological Cancers?
Hormone Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Prostate & Other Urological Cancers?
Urological cancers are primarily evaluated and managed by a medical oncologist with experience in genitourinary cancers, often working alongside a urologist for surgical considerations and a radiation oncologist when radiotherapy is part of the plan. In comprehensive centres, a multidisciplinary tumour board — which may also include pathologists, radiologists, and specialist nurses — reviews complex cases to ensure coordinated, evidence-based care.
How do I choose a doctor for Prostate & Other Urological Cancers?
When selecting a specialist, it is worth asking about their specific experience managing your cancer type (e.g. prostate, bladder, or kidney), whether the centre holds regular multidisciplinary tumour board meetings, and what follow-up and survivorship support are available after treatment. Access to advanced diagnostic imaging, clinical trials, and a dedicated patient navigator can also make a meaningful difference in the continuity and quality of your care.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.